Related references
Note: Only part of the references are listed.A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease
Chrysan J. Mohammed et al.
ANTIOXIDANTS (2022)
Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
Fatimah K. Khalaf et al.
ANTIOXIDANTS (2022)
Cardiovascular disease in patients with chronic kidney disease
Turgay Saritas et al.
HERZ (2020)
Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease
Chrysan J. Mohammed et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Role of Ca2+-ATPase 2a (ATP2A2), Ryanodine Receptors (RYR2), and Calsequestrin (CASQ2) Gene Polymorphisms in the Development of Heart Failure
T. Yu. Rebrova et al.
RUSSIAN JOURNAL OF GENETICS (2018)
Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease
Milica Miljkovic et al.
CLINICAL BIOCHEMISTRY (2018)
Diminished Antioxidant Activity of High‐Density Lipoprotein–Associated Proteins in Chronic Kidney Disease
David J. Kennedy et al.
Journal of the American Heart Association (2018)
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Simona E. Mihai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure
Muhammad Hammadah et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases
Jose M. Lou-Bonafonte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression
Daniela Martini et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Paraoxonase and atherosclerosis-related cardiovascular diseases
Dimitry A. Chistiakov et al.
BIOCHIMIE (2017)
Cause of Death in Patients with Reduced Kidney Function
Stephanie Thompson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
PON1 and Mediterranean Diet
Jose M. Lou-Bonafonte et al.
NUTRIENTS (2015)
Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure
Tiziana Angrisano et al.
PLOS ONE (2014)
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
Bharti Mackness et al.
ARCHIVES OF MEDICAL SCIENCE (2013)
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort et al.
LANCET (2013)
Paraoxonase 1: A better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus
Surajeet Kumar Patra et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2013)
Targeted Sarcoplasmic Reticulum Ca2+ ATPase 2a Gene Delivery to Restore Electrical Stability in the Failing Heart
Michael J. Cutler et al.
CIRCULATION (2012)
Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease
Ferenc Sztanek et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Aneta Otocka-Kmiecik et al.
PROGRESS IN LIPID RESEARCH (2012)
Paraoxonase 1 in Chronic Kidney Failure
Alejandro Gugliucci et al.
JOURNAL OF LIPIDS (2012)
Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Systolic Heart Failure
W. H. Wilson Tang et al.
CIRCULATION-HEART FAILURE (2011)
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog et al.
KIDNEY INTERNATIONAL (2011)
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
P. Stenvinkel
JOURNAL OF INTERNAL MEDICINE (2010)
Continuous Reduction of Plasma Paraoxonase Activity With Increasing Dialysis Vintage in Hemodialysis Patients
Bernhard F. Henning et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2010)
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects
Hagai Tavori et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Epistatic Genetic Determinants of Blood Pressure and Mortality in a Salt-Sensitive Hypertension Model
George T. Cicila et al.
HYPERTENSION (2009)
High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
Narayani Jayakumari et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2009)
Administration of exogenous erythropoietin β affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia
Judit Marsillach et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy
Jihad Elkareh et al.
HYPERTENSION (2007)
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy
DJ Kennedy et al.
HYPERTENSION (2006)
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999
RN Foley et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction
EE Morgan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II
KS Robertson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)
Low paraoxonase activity predicts coronary events in the caerphilly prospective study
B Mackness et al.
CIRCULATION (2003)
Cardiovascular complications in chronic kidney disease
MJ Sarnak
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat
D Kennedy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
A Tward et al.
CIRCULATION (2002)
Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene:: the REGICOR study
M Sentí et al.
ATHEROSCLEROSIS (2001)
Share Paper
